Plain-English translation of NCT07183150 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying stomach cancer surgery in people with advanced disease in the lower part of the stomach. Researchers want to understand the best way to remove certain lymph nodes (small glands that filter fluid in your body) during surgery, and where cancer is most likely to have spread to those nodes. By observing two different approaches to lymph node removal, doctors hope to improve outcomes for future patients.
When stomach cancer spreads, it often travels first to nearby lymph nodes. Doctors need to know which lymph nodes are most important to remove during surgery and where cancer cells are most likely to be found. This knowledge will help surgeons treat the disease more effectively and help future patients have better outcomes.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo surgery to remove part of your stomach and nearby lymph nodes using minimally invasive techniques (laparoscopic surgery). During the operation, your surgeon will carefully remove and examine lymph nodes from two specific areas to see where cancer has spread. Your doctor will track your recovery and monitor your health for at least 6 months after surgery as part of the study.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Enrollment target
~400 participants
Started
August 2025
Primary completion
August 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bin Ke, MD.
Tianjin Medical University Cancer Institute and Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.